Science ❯Medical Research ❯Clinical Trials

Drug Development

Clinical Trials Clinical Trials Neurology Neurodegenerative Diseases Access to Healthcare Drug Pricing Drug Efficacy Exercise Disease Prevention HIV/AIDS

FDA to Decide on Twice-Yearly HIV Preventive Drug Lenacapavir

Generic manufacturers are set to produce lenacapavir for as little as $25 per patient annually

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

HIV Drugs Linked to Reduced Alzheimer’s Risk in Landmark Study

CMS Rejects Medicare and Medicaid Coverage for Anti-Obesity Drugs